Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Mesothelioma × Axitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Carcinoma, Renal Cell 36 Kidney Neoplasms 9 Neoplasm Metastasis 7 Neoplasms 6 Melanoma 5 Colorectal Neoplasms 5 Glioblastoma 4 Carcinoma, Hepatocellular 4 Recurrence 3 Clear-cell metastatic renal cell carcinoma 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Liver Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Adenoid Cystic 2 cT2a N0NxM0 Renal Tumor 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Solitary Fibrous Tumors 1 Solid Malignancies 1 Skin Neoplasms 1 Sarcoma, Alveolar Soft Part 1 Salivary Gland Neoplasms 1 Relapsed Pediatric Solid Tumor 1 Radiation Therapy 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Ovarian Neoplasms 1

Interventions

Pemetrexed 22 Cisplatin 20 Nivolumab 8 Gemcitabine 7 Carboplatin 7 durvalumab 5 Ipilimumab 5 Bevacizumab 5 pembrolizumab 4 Radiotherapy, Intensity-Modulated 4 tremelimumab 3 niraparib 3 Oxaliplatin 3 Drug Therapy 3 Cyclophosphamide 3 Cerebral Decortication 3 Blood Specimen Collection 3 sargramostim 2 Thoracoscopy 2 Surveys and Questionnaires 2 Sorafenib 2 Radiosurgery 2 Magnesium Sulfate 2 Leucovorin 2 Imatinib Mesylate 2 Hyperthermic Intraperitoneal Chemotherapy 2 Doxorubicin 2 Dexamethasone 2 tislelizumab 1 spartalizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01211275 2017-02-28

N08CPA

The Netherlands Cancer Institute

Phase 1/2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡